SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Abraham IM, Han SK, Todman MG, Korach KS, Herbison AE. 2003. Estrogen receptor beta mediates rapid estrogen actions on gonadotropin-releasing hormone neurons in vivo. J Neurosci 23(13): 57715777.
  • Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M. 2005. Palmitoylation-dependent estrogen receptor alpha membrane localization: Regulation by 17beta-estradiol. Mol Biol Cell 16(1): 231237.
  • Balasenthil S, Barnes CJ, Rayala SK, Kumar R. 2004. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Lett 567(2-3): 243247.
  • Baldi E, et al. 2000. A novel functional estrogen receptor on human sperm membrane interferes with progesterone effects. Mol. Cell. Endocrinol 161: 3135.
  • Barnes CJ, Vadlamudi RK, Kumar R. 2004. Novel estrogen receptor coregulators and signaling molecules in human diseases. Cell Mol Life Sci 61: 281291.
  • Björnström L, Sjöberg M. 2004. Estrogen receptor-dependent activation of AP-1 via non-genomic signalling. Nucl Recept 2: 3.
  • Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and-independent mechanisms. Science 286: 13581362.
  • Boonyaratanakornkit V, Porter M, Ribon V, Sherman L, Anderson SA, Miller WT, Edwards DP. 2001. Progesterone receptor contains a proline rich sequence in the amino terminus that directly interacts with SH3 domains and activates Src family tyrosine kinases. Mol Cell 8: 269280.
  • Buck M, Poli V, van der Geer P, Chojkier M, Hunter T. 1999. Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP ß is required for hepatocyte proliferation induced by TGFα. Mol Cell 4: 10871092.
  • Bunone G, Briand PA, Miksicek RJ, Picard D. 1996. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15: 21742183.
  • Cabodi S, Moro L, Baj G, Smeriglio M, Di Stefano P, Gippone S, Surico N, Silengo L, Turco E, Tarone G, Defilippi P. 2004. p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J Cell Sci 117(8): 16031611.
  • Cardona-Gomez P, Mendez P, Garcia-Segura LM. 2002. Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus. Mol Brain Res 107: 8088.
  • Cardona-Gomez P, Perez M, Avila J, Garcia-Segura LM, Wandosell F. 2004. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol Cell Neurosci 25(3): 363373.
  • Carmeci DA, Thompson HZ, Ring U, Francke XX, Weigel RJ. 1997. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45: 607617.
  • Castets F, Bartoli M, Barnier J, Bailat G, Salin P, Moqrich A, Bourgeois J, Denizot F, Rougon GCG, Monneron A. 1996. A novel calmodulin-binding protein, belonging to the WD-repeat family, is localized in dendrites of a subset of CNS neurons. J Cell Biol 134: 10511062.
  • Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW. 2002. ERbeta has nongenomic action in caveolae. Mol Endocrinol 16(5): 938946.
  • Chambliss KL, Simon L, Yuhanna IS, Mineo C, Shaul PW. 2005. Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: Role of ERalpha domains with known nuclear functions. Mol Endocrinol 19(2): 277289.
  • Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. 1999. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401406.
  • Chen JQ, Delannoy M, Cooke C, Yager JD. 2004. Mitochondrial localization of ERalpha and ER beta in human MCF7 cells. Am J Physiol Endocrinol Metab 286(6): E1011E1022.
  • Cruzalegui FH, Cano E, Treisman R. 1999. ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry. Oncogene 18: 79487957.
  • Denninger JW, Marletta MA. 1999. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1411: 334350.
  • Dickson RB, Lippmann ME. 1998. Growth regulation of normal and malignant breast epithelium. In: BlandKI, CopelandEM, editors. The breast: Comprehensive management of benign and malignant diseases. Philadelphia: Saunders. pp 518563.
  • Dimmeler SI, Fleming B, Fisslthaler C, Hermann R, Busse AM, Zeiher XXX. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601605.
  • Doolan CM, Condliffe SB, Harvey BJ. 2000. Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca2+]i by 17β-oestradiol in rat distal colon. Br J Pharmacol 129: 13751386.
  • Dos Santos EG, Dieudonne MN, Pecquery R, Le Moal V, Giudicelli Y, Lacasa D. 2002. Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 143: 930940.
  • Driggers PH, Segars JH. 2002. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 13: 422427.
  • Duan R, Xie W, Burghardt RC, Safe S. 2001. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J Biol Chem 276: 1159011598.
  • Duenas M, Torres-Aleman I, Naftolin F, Garcia-Segura LM. 1996. Interaction of insulin-like growth factor-I and estradiol signaling pathways on hypothalamic neuronal differentiation. Neuroscience 74: 531539.
  • Endoh H, Maruyama K, Masuhiro Y, Kobayashi Y, Goto M, Tai H, Yanagisawa J, Metzger D, Hashimoto S, Kato S. 1999. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor α. Mol Cell Biol 19: 53635372.
  • Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL. 1988. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241: 8486.
  • Farhat MY, Lavigne MC, Ramwell PW. 1996. The vascular protective effects of estrogen. FASEB J 10: 615624.
  • Fernando RI, Wimalasena J. 2004. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell 15(7): 32663284.
  • Filardo EJ. 2002. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: A novel signaling pathway with potential significance for breast cancer. J steroid Biochem Mol Biol 80(2): 231238.
  • Garcia E, Lacasa D, Giudicelli Y. 2000. Estradiol stimulation of c-fos and c-jun expressions and activator protein-1 desoxyribonucleic acid binding activity in rat white adipocyte. Endocrinology 141: 28372846.
  • Garcia-Segura LM, Azcoitia I, DonCarlos LL. 2001. Neuroprotection by estradiol. Prog Neurobiol 63: 2960.
  • Gether U. 2000. Uncovering molecular mechanisms involved in activation of G-protein-coupled receptors. Endocr Rev 21: 90113.
  • Govind AP, Thampan RV. 2003. Membrane associated estrogen receptors and related proteins: Localization at the plasma membrane and the endoplasmic reticulum. Mol Cell Biochem 253(1-2): 233240.
  • Gu Q, Moss RL. 1996. 17ß-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J Neurosci 16: 36203629.
  • Gu Q, Korach KS, Moss RL. 1999. Rapid action of 17ß-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology 140: 660666.
  • Guo X, Razandi M, Pedram A, Kasab G, Levin ER. 2005. Estrogen induces vascular wall dilation: Mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 280(20): 1970419710.
  • Ho KJ, Liao JK. 2002. Non-nuclear actions of estrogen: New targets for prevention and treatment of cardiovascular disease. Mol Interv 2(4): 219228.
  • Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS. 1996. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137: 17351744.
  • Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. 2000. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 16;275(24): 1844718453.
  • Karin M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 1648316486.
  • Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 14911494.
  • Kawagoe J, Ohmichi M, Takahashi T, Ohshima C, Mabuchi S, Takahashi K, Igarashi H, Mori-Abe A, Saitoh M, Du B, Ohta T, Kimura A, Kyo S, Inoue M, Kurachi H. 2003. Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line. J Biol Chem 278: 4336343372.
  • Kelly MJ, Levin ER. 2001. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12(4): 152156.
  • Kelly MJ, Wagner EJ. 1999. Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol Metabol 10(9): 369374.
  • Keshamouni VG, Mattingly RR, Reddy KB. 2002. Mechanism of 17-ß-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-δ. J Biol Chem 277: 2255822565.
  • Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas MC. 2001. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors dissociation from transcriptional activity. Cell 104(5): 719730.
  • Kousteni S, Bellido CT, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC. 2002. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298: 843846.
  • Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC. 2003. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111: 16511664.
  • Kumar R, Wang RA, Majundar A, Talukder AH, Mandal M, Yang Z, Bhageri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK. 2002. A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature 418(6898): 654657.
  • Le Mallay VB, Grosse B, Lieberherr M. 1997. Phospholipase C beta and membrane action of calcitriol and estradiol. J Biol Chem 272: 1190211907.
  • Leevers SJ, Vanhaesebroeck B, Waterfield MD. 1999. Signalling through phosphoinositide 3-kinases: The lipids take centre stage. Curr Opin Cell Biol 11(2): 219225.
  • Levin ER. 2002. Cellular functions of plasma membrane estrogen receptors. Steroids 67: 471475.
  • Lieberherr M, Grosse B. 1994. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem 269: 72177223.
  • Lieberherr M, Grosse B, Kachkache M, Balsan S. 1993. Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors. J Bone Miner Res 8: 13651376.
  • Liu D, Dillon JS. 2002. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Gα (i2,3). J Biol Chem 277: 2137921388.
  • Loomis AK, Thomas P. 2000. Effects of estrogens and xenoestrogens on androgen production by Atlantic croaker testes in vitro: Evidence for a nongenomic action mediated by an estrogen membrane receptor. Biol Reprod 62: 9951004.
  • Losel R, Wehling M. 2003. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 4(1): 4656.
  • Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH. 2004. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor α. PNAS 101(49): 1712617131.
  • Manavathi B, Nair SS, Wang RA, Kumar R, Vadlamudi RK. 2005. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation. Cancer Res 65(13): 55715577.
  • Martin GS. 2001. The hunting of the Src. Nat Rev Mol Cell Biol 2: 467473.
  • Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A. 2000. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulinlike growth factor I. Endocrinology 141: 45034511.
  • Mazumdar A, Wang RA, Mistra SK, Adam L, Bagheri-Yarmand R, Mandal M, Vadlamudi RK, Kumar R. 2001. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 3(1): 3037.
  • Mendelsohn ME. 2002. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 90(1A): 3F6F.
  • Mendez P, Azcoitia I, Garcia-Segura LM. 2003. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Mol. Brain Res 112: 170176.
  • Michalides R, Griekspoor A, Balkenende A, Verwoerd D, Janssen L, Jalink K, Floore A, Velds A, van't Veer L, Neefjes J. 2004. Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer. Cancer Cell 5: 597605.
  • Migliaccio A, Di Domenico M, Castoria G, De Falco A, Bontempo P, Nola E, Auricchio F. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 12921300.
  • Moncada S, Higgs A. 1993. The L-arginine-nitric oxide pathway. N Engl J Med 329: 20022012A.
  • Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL. 1992. A new, nongenomic estrogen action: The rapid release of intracellular calcium. Endocrinology 131: 13051312.
  • Moro L, Reineri S, Piranda D, Pietrapiana D, Lova P, Bertoni A, Graziani A, Defilippi P, Canobbio I, Torti M, Sinigaglia F. 2005. Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase. Blood 105: 115121.
  • Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B. 2000. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor ß. Proc Natl Acad Sci USA 97: 1160311608.
  • Nelson KG, Takahashi T, Bossert NL, Walmer DL, McLachlan JA. 1991. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci USA 88: 2125.
  • Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. 2001. Mechanisms of estrogen action. Physiol Rev 81: 15351565.
  • Norfleet AM, Thomas ML, Gametchu B, Watson CS. 1999. Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140: 38053814.
  • O'Lone R, Frith MC, Karlsson EK, Hansen U. 2004. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18(8): 18591875.
  • O'Neill GM, Fashena SJ, Golemis EA. 2000. Integrin signalling: A new Cas(t) of characters enters the stage. Trends Cell Biol 10: 111119.
  • Okamoto T, Schlegel A, Scherer PE, Lisanti MP. 1998. Caveolins, a family of scaffolding proteins fro organizing “preassembled signal complexes” at the plasma membrane. J Biol Chem 273: 54195422.
  • Orihuela PA, Parada-Bustamante A, Cortes PP, Gatica C, Croxatto HB. 2003. Estrogen receptor, cyclic adenosine monophosphate, and protein kinase A are involved in the nongenomic pathway by which estradiol accelerates oviductal oocyte transport in cyclic rats. Biol Reprod 68(4): 12251231.
  • Pappas TC, Gametchu B, Watson CS. 1995. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9: 404410.
  • Pedram A, Razandi M, Aitkenhead M, Hughes CCW, Levin ER. 2002. Integration of the non-genomic and genomic actions of estrogen: membrane initiated signaling by steroid (MISS) to transcription and cell biology. J Biol Chem 277: 5076850775.
  • Picotto G, Vazquez G, Boland R. 1999. 17β-oestradiol increases intracellular Ca2+ concentration in enterocytes. Potential role of phospholipase C-dependent store-operated Ca2+ influx. Biochem J 339: 7177.
  • Pietras RJ, Szego CM. 1977. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265(5589): 6972.
  • Pratt MA, Satkunaratnam A, Novosad DM. 1998. Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells. Mol Cell Biochem 189: 119125.
  • Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, Kelly MJ. 2003. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 23: 95299540.
  • Quesada A, Etgen AM. 2002. Functional interactions between estrogen and insulin-like growth factor-I in the regulation of alpha 1B-adrenoceptors and female reproductive function. J. Neurosci 22: 24012408.
  • Ravichandran RS. 2001. Signaling via Shc family adapter proteins. Oncogene 1; 20(44): 63226330.
  • Razandi M, Pedram A, Greene GL, Levin ER. 1999. Cell membrane and nuclear estrogen receptors derive from a single transcript: Studies of ERα and ERß expressed in CHO cells. Mol Endocrinol 13: 307319.
  • Razandi M, Pedram A, Levin ER. 2000. Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem 275(49): 3854038546.
  • Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin R. 2003. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol 23: 16331646.
  • Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA. 1994. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89: 5260.
  • Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. 2005. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 11; 307(5715): 16251630.
  • Riggs BL, Khosla S, Melton LJ. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23: 279302.
  • Romashkova JA, Makarov SS. 1999. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 8690.
  • Ropero AB, Soria B, Nadal A. 2002. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol 16: 497505.
  • Rowan BG, Weigel NL, O'Malley BW. 2000. Phosphorylation of steroid receptor coactivator-1: Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275: 44754483.
  • Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP. 1999. Caveolin-1 potentiates estrogen receptor α (ERα) signaling. J Biol Chem 274: 3355133556.
  • Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. 2000. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538541.
  • Simpson ER, Misso M, Hewitt KN, Hill RA, Boon WC, Jones ME, Kovacic A, Zhou J, Clyne CD. 2005. Estrogen–the good, the bad, and the unexpected. Endocr Rev 26(3): 322330.
  • Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ. 2002. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol Endocrinol 16(1): 116127.
  • Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. 2004. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci USA 101(7): 20762081.
  • Stefano GB, Prevot B, Beauvillain JC, Fimiani C, Welter I, Cadet P, Breteon C, Prestel J, Saljet M, Bilfinger TV. 1999. Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: Evidence for an estrogen surface receptor. J Immunol 163: 37583763.
  • Sukocheva OA, Wang L, Albanese N, Pitson SM, Vadas MA, Xia P. 2003. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol Endocrinol 17(10): 20022012.
  • Syed F, Khosla S. 2005. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328(3): 688696.
  • Thomas P, Pang Y, Filardo EJ, Dong J. 2005. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624632.
  • Thornton MJ. 2002. The biological actions of estrogens on skin. Exp Dermatol 11: 487502.
  • Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly ES Jr., Nethrapalli IS, Tinnikov AA. 2002. ER-X: A novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 22: 83918401.
  • Vadlamudi RK, Wang RA, Mazumdar A, Kim Y, Shin J, Sahin A, Kumar R. 2001. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor. J. Biol. Chem. 276: 3827238279.
  • Vadlamudi RK, Manavathi B, Balasenthil S, Ashegul S, Bhageri-Yarmand R, Kuamr R. 2005. Functions implications for altered localization of PELP1 in cancer cells. Cancer Res 65(17): 77247732.
  • Verdier-Sevrain S, Yaar M, Cantatore J, Traish A, Gilchrest BA. 2004. Estradiol induces proliferation of keratinocytes via a receptor mediated mechanism. FASEB J 18(11): 12521254.
  • Wang RA, Mazumdar A, Vadlamudi RK, Kumar R. 2002. P21-activated kinase-1 hosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J 21(20): 54375447.
  • Watson CS, Campbell CH, Gametchu B. 2002. The dynamic and elusive membrane estrogen receptor-α. Steroids 67: 429437.
  • Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. 2002. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99: 1478314788.
  • Yamamoto K, Altschuler D, Wood E, Horlick K, Jacobs S, Lapetina EG. 1992. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J Biol Chem 267(16): 1133711343.
  • Ylikomi T, Bocquel MT, Berry M, Gronemeyer H, Chambon P. 1992. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J 11(10): 36813694.
  • Zhang Z, Kumar R, Santen RJ, Song RX. 2004. Abstract The role of adapter protein Shc in estrogen non-genomic action. Steroids 69: 523529.
  • Zhu Y, Bond J, Thomas P. 2003. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100: 22372242.